Increased static pressure promotes migration of vascular smooth muscle cells: Involvement of the Rho-kinase pathway

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 1, 2008, Pages 55-61

  Onoue, Noriko ^a   Nawata, Jun ^a   Tada, Tomohiro ^a   Zhulanqiqige, Doe ^a   Wang, Huan ^a   Sugimura, Koichiro ^a   Fukumoto, Yoshihiro ^a   Shirato, Kunio ^a   Shimokawa, Hiroaki ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Integrins; Migration; Rho kinase; Static pressure; Vascular smooth muscle cells

Indexed keywords

FASUDIL; FIBRONECTIN; GELATINASE A; LAMININ; RHO KINASE; VITRONECTIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; NONHUMAN; PRESSURE CHAMBER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; ANTIBODIES; ANTIGENS, CD29; CELL MOVEMENT; CELL PROLIFERATION; INTEGRIN BETA CHAINS; INTEGRIN BETA3; MALE; MUSCLE, SMOOTH, VASCULAR; PRESSURE; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 38349132756     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31815b9d26     Document Type: Article

References (46)

1. Forough R, Koyama N, Hasenstab D, et al. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res. 1996;79:812-820.
2. Matsuno H, Stassen JM, Vermylen J, et al. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;90:2203-2206.
3. Choi ET, Engel L, Callow AD, et al. Inhibition of neointimal hyperplasia by blocking αV β3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg. 1994;19:125-134.
4. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951;41:279-281.
5. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
6. Hishikawa K, Nakaki T, Marumo T, et al. Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. J Clin Invest. 1994;93:1975-1980.
7. Watase M, Awolesi MA, Ricotta J, et al. Effect of pressure on cultured smooth muscle cells. Life Sci. 1997;61:987-996.
8. Moiseeva EP. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res. 2001;52:372-386.
9. Abedi H, Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res. 1995;30:544-556.
10. Rocnik EF, Chan BM, Pickering JG. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration. J Clin Invest. 1998;101:1889-1898.
11. Clyman RI, Mauray F, Kramer RH. β1 and β3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res. 1992;200:272-284.
12. Slepian MJ, Massia SP, Dehdashti B, et al. β3-integrins rather than β1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration. Circulation. 1998;97:1818-1827.
13. Pasqualini R, Bodorova J, Ye S, et al. A study of the structure, function and distribution of β5 integrins using novel anti-β5 monoclonal antibodies. J Cell Sci. 1993;105:101-111.
14. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol. 2005;25:1767-1775.
15. Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279:509-514.
16. Amano M, Chihara K, Kimura K, et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science. 1997;275:1308-1311.
17. Alblas J, Ulfman L, Hordijk P, et al. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell. 2001;12:2137-2145.
18. Seasholtz TM, Majumdar M, Kaplan DD, et al. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ Res. 1999;84:1186-1193.
19. Ohtsu H, Mifune M, Frank GD, et al. Signal-crosstalk between Rho/ ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Arterioscler Thromb Vasc Biol. 2005;25:1831-1836.
20. Smith JB, Brock TA. Analysis of angiotensin-stimulated sodium transport in cultured smooth muscle cells from rat aorta. J Cell Physiol. 1983;114:284-290.
21. Nakamura A, Isoyama S, Watanabe T, et al. Heterogeneous smooth muscle cell population derived from small and larger arteries. Microvasc Res. 1998;55:14-28.
22. Lauzier MC, Page EL, Michaud MD, et al. Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells. Endocrinology. 2007;148:4023-4031.
23. Wen JK, Han M, Zheng B, et al. Comparison of gene expression patterns and migration capability at quiescent and proliferating vascular smooth muscle cells stimulated by cytokines. Life Sci. 2002;70:799-807.
24. Jones JI, Gockerman A, Busby WH Jr, et al. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α 5 β 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA. 1993;90:10553-10557.
25. Majack RA, Clowes AW. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol. 1984;118:253-256.
26. Klemke RL, Cai S, Giannini AL, et al. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol. 1997;137:481-492.
27. Matsumoto Y, Uwatoku T, Oi K, et al. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol. 2004;24:181-186.
28. Hattori T, Shimokawa H, Higashi M, et al. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation. 2004;109:2234-2239.
29. Thubrikar MJ, Robicsek F. Pressure-induced arterial wall stress and atherosclerosis. Ann Thorac Surg. 1995;59:1594-1603.
30. Schwartz SM. Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest. 1997;99:2814-2816.
31. Goetze S, Xi XP, Kawano Y, et al. TNF-α-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension. 1999;33:183-189.
32. Sadoshima J, Jahn L, Takahashi T, et al. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem. 1992;267:10551-10560.
33. Carver W, Nagpal ML, Nachtigal M, et al. Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res. 1991;69:116-122.
34. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-1032.
35. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
36. Graf K, Xi XP, Yang D, et al. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 1997;29:334-339.
37. 2, and high intravascular pressure. Circulation. 2005;111:2364-2372.
38. Bardy N, Merval R, Benessiano J, et al. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res. 1996;79:70-78.
39. Dufourcq P, Couffinhal T, Alzieu P, et al. Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation. Cardiovasc Res. 2002;53:952-962.
40. Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin αV β3 binding to vitronectin. Nature. 1996;383:441-443.
41. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
42. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest. 1995;96:2364-2372.
43. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629-635.
44. Blaschke F, Stawowy P, Goetze S, et al. Hypoxia activates β1-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cells. Biochem Biophys Res Commun. 2002;296:890-896.
45. Numaguchi K, Eguchi S, Yamakawa T, et al. Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res. 1999;85:5-11.
46. Goldschmidt ME, McLeod KJ, Taylor WR. Integrin-mediated mechano-transduction in vascular smooth muscle cells: frequency and force response characteristics. Circ Res. 2001;88:674-680.